Literature DB >> 16889610

Prednisolone suppresses the function and promotes apoptosis of plasmacytoid dendritic cells.

P P C Boor1, H J Metselaar, S Mancham, H W Tilanus, J G Kusters, J Kwekkeboom.   

Abstract

Organ transplant recipients are highly susceptible to viral infections early after transplantation. Plasmacytoid dendritic cells (PDC) play a major role in antiviral immunity. Therefore, we determined the numbers of circulating PDC after liver transplantation (LTX) and established the effects of immunosuppressive drugs on PDC survival and function. PDC were determined longitudinally in 13 LTX recipients treated with prednisone and cyclosporin or tacrolimus. Purified PDC were cultured with or without clinically relevant concentrations of cyclosporin, tacrolimus or prednisolone. Apoptosis induction was monitored by determination of active caspase-3, nuclear condensation and annexin-V/7AAD staining. After LTX, a 4-fold reduction in the number of circulating PDC was observed (p < 0.01), which recovered partially after discontinuation of prednisone treatment. In vitro, prednisolone induced apoptosis in PDC, while cyclosporin and tacrolimus did not. Higher doses of prednisolone were needed to induce apoptosis in Toll-like receptor (TLR)-stimulated PDC. However, non-apoptosis inducing concentrations of prednisolone suppressed interferon-alpha production, upregulation of co-stimulatory molecules and allo-stimulatory capacity of TLR-stimulated PDC. In conclusion, prednisolone induces apoptosis in PDC, which explains the decline in circulating PDC numbers after transplantation. Moreover, prednisolone suppresses the functions of TLR-stimulated PDC. Therefore, corticosteroid-free immunosuppressive therapy may reduce the number and severity of viral infections after transplantation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889610     DOI: 10.1111/j.1600-6143.2006.01476.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  21 in total

1.  Impairment of circulating myeloid dendritic cells in immunosuppressed liver transplant recipients.

Authors:  B M Bosma; H J Metselaar; W M W Tra; S Mancham; E J Kuipers; H W Tilanus; J Kwekkeboom
Journal:  Clin Exp Immunol       Date:  2007-07-23       Impact factor: 4.330

Review 2.  Type I interferon and systemic lupus erythematosus.

Authors:  Keith B Elkon; Vivian V Stone
Journal:  J Interferon Cytokine Res       Date:  2011-08-22       Impact factor: 2.607

3.  TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.

Authors:  Cristiana Guiducci; Mei Gong; Zhaohui Xu; Michelle Gill; Damien Chaussabel; Thea Meeker; Jean H Chan; Tracey Wright; Marilynn Punaro; Silvia Bolland; Vassili Soumelis; Jacques Banchereau; Robert L Coffman; Virginia Pascual; Franck J Barrat
Journal:  Nature       Date:  2010-06-17       Impact factor: 49.962

Review 4.  Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Authors:  Alberto Grassi; Giorgio Ballardini
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

5.  Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions.

Authors:  P P C Boor; H J Metselaar; S Mancham; L J W van der Laan; J Kwekkeboom
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

6.  A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset.

Authors:  Christian Bryant; Phillip D Fromm; Fiona Kupresanin; Georgina Clark; Kenneth Lee; Candice Clarke; Pablo A Silveira; Hayley Suen; Ross Brown; Elizabeth Newman; Ilona Cunningham; P Joy Ho; John Gibson; Kenneth Bradstock; Douglas Joshua; Derek Nj Hart
Journal:  Immunol Cell Biol       Date:  2016-01-21       Impact factor: 5.126

Review 7.  Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?

Authors:  J J Auletta; S M Devine; E K Waller
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

Review 8.  Challenges of recurrent hepatitis C in the liver transplant patient.

Authors:  Renumathy Dhanasekaran; Roberto J Firpi
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 9.  Human dendritic cells and transplant outcome.

Authors:  Mario G Solari; Angus W Thomson
Journal:  Transplantation       Date:  2008-06-15       Impact factor: 4.939

10.  Antagonist-mediated down-regulation of Toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus.

Authors:  Shui-Lian Yu; Paul K S Chan; Chun-Kwok Wong; Cheuk-Chun Szeto; Suzanne C Ho; Karine So; May M Y Yu; So-Fan Yim; Tak-Hong Cheung; Martin C S Wong; Jo L K Cheung; Apple C M Yeung; Edmund K Li; Lai-Shan Tam
Journal:  Arthritis Res Ther       Date:  2012-04-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.